OTLK icon

Outlook Therapeutics

15 hedge funds and large institutions have $18.2M invested in Outlook Therapeutics in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$814K
2 +$651K
3 +$40.3K
4
JAM
JW Asset Management
Florida
+$17.9K
5
UBS Group
UBS Group
Switzerland
+$2.8K

Top Sellers

1 -$850K
2 -$757K
3 -$678K
4
SM
Sabby Management
Florida
-$106K
5
Millennium Management
Millennium Management
New York
-$89.6K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.74M
2
$3.76M
3
$2.51M
4
$2.06M
5
$841K
6
$788K
7
$525K
8
$390K
9
$296K
10
$177K
11
$88K
12
$45K
13
$16K
14
$9K
15
16
17
18